Literature DB >> 22478955

Clopidogrel and proton pump inhibitors: a new drug interaction?

Doson Chua1, Jennifer Bolt, Angela Lo, Anita Lo.   

Abstract

Entities:  

Year:  2010        PMID： 22478955      PMCID： PMC2832571          DOI： 10.4212/cjhp.v63i1.869

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  13 in total

Review 1.  Drug-drug interaction between clopidogrel and the proton pump inhibitors.

Authors:  Nicholas B Norgard; Kathryn D Mathews; Geoffrey C Wall
Journal:  Ann Pharmacother       Date:  2009-05-26       Impact factor: 3.154

Review 2.  Clopidogrel in acute coronary syndromes.

Authors:  Doson Chua; Andrew Ignaszewski
Journal:  BMJ       Date:  2009-04-14

3.  ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Authors:  Deepak L Bhatt; James Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley
Journal:  Circulation       Date:  2008-10-03       Impact factor: 29.690

Review 4.  Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

Authors:  Michelle L O'Donoghue; Eugene Braunwald; Elliott M Antman; Sabina A Murphy; Eric R Bates; Yoseph Rozenman; Alan D Michelson; Raymond W Hautvast; Peter N Ver Lee; Sandra L Close; Lei Shen; Jessica L Mega; Marc S Sabatine; Stephen D Wiviott
Journal:  Lancet       Date:  2009-08-31       Impact factor: 79.321

5.  A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Authors:  David N Juurlink; Tara Gomes; Dennis T Ko; Paul E Szmitko; Peter C Austin; Jack V Tu; David A Henry; Alex Kopp; Muhammad M Mamdani
Journal:  CMAJ       Date:  2009-01-28       Impact factor: 8.262

6.  Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Authors:  Martine Gilard; Bertrand Arnaud; Jean-Christophe Cornily; Grégoire Le Gal; Karine Lacut; Geneviève Le Calvez; Jacques Mansourati; Dominique Mottier; Jean-François Abgrall; Jacques Boschat
Journal:  J Am Coll Cardiol       Date:  2008-01-22       Impact factor: 24.094

7.  Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.

Authors:  Alan R Shuldiner; Jeffrey R O'Connell; Kevin P Bliden; Amish Gandhi; Kathleen Ryan; Richard B Horenstein; Coleen M Damcott; Ruth Pakyz; Udaya S Tantry; Quince Gibson; Toni I Pollin; Wendy Post; Afshin Parsa; Braxton D Mitchell; Nauder Faraday; William Herzog; Paul A Gurbel
Journal:  JAMA       Date:  2009-08-26       Impact factor: 56.272

8.  Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel.

Authors:  Jolanta M Siller-Matula; Alexander O Spiel; Irene M Lang; Gerhard Kreiner; Guenter Christ; Bernd Jilma
Journal:  Am Heart J       Date:  2008-11-06       Impact factor: 4.749

9.  Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.

Authors:  David S Small; Nagy A Farid; Christopher D Payne; Govinda J Weerakkody; Ying G Li; John T Brandt; Daniel E Salazar; Kenneth J Winters
Journal:  J Clin Pharmacol       Date:  2008-02-26       Impact factor: 3.126

10.  Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

Authors:  P Michael Ho; Thomas M Maddox; Li Wang; Stephan D Fihn; Robert L Jesse; Eric D Peterson; John S Rumsfeld
Journal:  JAMA       Date:  2009-03-04       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.